Thanks to the recently passed Inflation Reduction Act (IRA), premiums for Medicare Part D outpatient drug plans will start to rise over the next few years. The increase will be 6 percent a year, according to the Congressional Budget Office (CBO) and private forecasts.
To make matters worse, in a few more years, the vast majority of Part D enrollees will start paying more for drugs they get from their local pharmacies than they would have paid under a s...